Rallybio (RLYB)
Develops rare-disease therapies while pursuing a merger with oncology developer Avenzo.
$17.12
At close+0.43 (+2.58%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$1.44
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.25−$0.21−$0.22−$0.14−$1.11−$1.46−$1.09Pending
Estimate−$0.27−$0.21−$0.20−$0.25−$1.24−$1.20−$1.28−$1.44
Surprise+7.4%0.0%−12.8%+44.0%+10.5%−21.7%+14.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$38.0K$212.0K$212.0K$212.0K$222.0K$212.0K—Pending
Estimate$149.5K—$66.7K$66.7K$100.0K$212.0K——
Surprise−74.6%—+218.0%+218.0%+122.0%0.0%——
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.44 | — | — |
| Aug 2026 | −$1.28 | −$1.09 | +14.8% |
| May 2026 | −$1.20 | −$1.46 | −21.7% |
| Mar 2026 | −$1.24 | −$1.11 | +10.5% |
| Nov 2025 | −$0.25 | −$0.14 | +44.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$1.44 | — | — | — | — | — | — |
| Aug 6, 2026 | −$1.28 | −$1.09 | +14.8% | — | — | — | +0.3% |
| May 13, 2026 | −$1.20 | −$1.46 | −21.7% | $212.0K | $212.0K | 0.0% | −1.0% |
| Mar 12, 2026 | −$1.24 | −$1.11 | +10.5% | $100.0K | $222.0K | +122.0% | −1.0% |
| Nov 6, 2025 | −$0.25 | −$0.14 | +44.0% | $66.7K | $212.0K | +218.0% | −2.2% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 13, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 12, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 7, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 15, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 9, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||